{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:21:31Z","timestamp":1768526491501,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/maj.0b013e31818c0134","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T15:33:15Z","timestamp":1242919995000},"page":"317-320","source":"Crossref","is-referenced-by-count":29,"title":["Rifampin Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection"],"prefix":"10.1016","volume":"337","author":[{"given":"Francis F.","family":"Fountain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy H.","family":"Self","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31818c0134_bb0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"Treatment of tuberculosis","volume":"167","author":"ATS\/CDC\/IDSA Joint Statement","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong","volume":"145","author":"Hong Kong Chest Service, Tuberculosis Research Centre, Madras, British Medical Research Council","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0025","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1164\/ajrccm.154.5.8912767","article-title":"Rifampin preventative therapy for tuberculosis in Boston\u2019s homeless","volume":"154","author":"Polesky","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0030","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1164\/ajrccm.155.5.9154885","article-title":"Rifampin preventative therapy for tuberculosis: experience with 157 adolescents","volume":"155","author":"Villarino","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampin for 4months versus isoniazid for 9months","volume":"170","author":"Menzies","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0040","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampin and isoniazid for treatment of latent tuberculosis: a retrospective study","volume":"166","author":"Page","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0045","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1378\/chest.130.6.1712","article-title":"Enhancement of treatment completion for latent tuberculosis infection with 4months of rifampin","volume":"130","author":"Lardizabal","year":"2006","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0050","first-page":"160","article-title":"Successful use of rifampicin for Hispanic foreign-born patients with latent tuberculosis infection","volume":"12","author":"Haley","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7 year evaluation from a public health tuberculosis clinic","volume":"128","author":"Fountain","year":"2005","journal-title":"Chest"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0060","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0070","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1164\/ajrccm.157.6.9711039","article-title":"Antituberculosis drug-induced hepatotoxicity: the role of hepatitis C virus and the human immunodeficiency virus","volume":"157","author":"Ungo","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0075","first-page":"393","article-title":"Les icteres au cours du traitement par la rifampicine (12 observations)","volume":"33","author":"Lesobre","year":"1969","journal-title":"Rev Tuberc (Paris)"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0007-0971(70)80034-1","article-title":"Jaundice after rifampicin","volume":"64","author":"Lees","year":"1970","journal-title":"Brit J Dis Chest"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0085","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1136\/bmj.3.5767.182","article-title":"Rifampicin jaundice","volume":"3","author":"Gabriel","year":"1971","journal-title":"BMJ"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.13.5.366","article-title":"Effect of rifampicin on liver function in man","volume":"13","author":"Capelle","year":"1972","journal-title":"Gut"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1742-1241.2001.tb10985.x","article-title":"Rifampicin test in the diagnosis of Gilbert\u2019s syndrome","volume":"55","author":"Erdil","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1179\/joc.2003.15.3.248","article-title":"Treatment of human brucellosis with rifampin plus minocycline","volume":"15","author":"Cascio","year":"2003","journal-title":"J Chemother"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0105","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archinte.162.9.985","article-title":"Rifampin and rifabutin drug interactions","volume":"162","author":"Finch","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1097\/MAJ.0b013e31818c0134_bb0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/MAJ.0b013e31814a586a","article-title":"Update on rifampin and rifabutin drug interactions","volume":"335","author":"Baciewicz","year":"2008","journal-title":"Am J Med Sci"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291531990X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291531990X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T18:49:19Z","timestamp":1710355759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296291531990X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S000296291531990X"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31818c0134","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}